SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells

Linda Zhang,Joanne I Hsu,Etienne D Braekeleer,Chun-Wei Chen,Tajhal D Patel,Alejandra G Martell,Anna G Guzman,Katharina Wohlan,Sarah M Waldvogel,Hidetaka Uryu,Ayala Tovy,Elsa Callen,Rebecca L Murdaugh,Rosemary Richard,Sandra Jansen,Lisenka Vissers,Bert B A de Vries,Andre Nussenzweig,Shixia Huang,Cristian Coarfa,Jamie Anastas,Koichi Takahashi,George Vassiliou,Margaret A Goodell
DOI: https://doi.org/10.7554/eLife.91611
IF: 7.7
2024-06-18
eLife
Abstract:The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase Mg2+/Mn2+-dependent 1D) is a master negative regulator of the response; gain-of-function mutations and amplifications of PPM1D are found across several human cancers making it a relevant pharmacological target. Here, we used CRISPR/Cas9 screening to identify synthetic-lethal dependencies of PPM1D, uncovering superoxide dismutase-1 (SOD1) as a potential target for PPM1D-mutant cells. We revealed a dysregulated redox landscape characterized by elevated levels of reactive oxygen species and a compromised response to oxidative stress in PPM1D-mutant cells. Altogether, our results demonstrate a role for SOD1 in the survival of PPM1D-mutant leukemia cells and highlight a new potential therapeutic strategy against PPM1D-mutant cancers.
What problem does this paper attempt to address?